ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 340847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 340847; 2) Community: the network communities that were significantly associated with the response to NSC 340847; 3) Molecule: the relationships between components within communities and NSC 340847; 4) MDR: the compounds that were significantly associated with the NSC 340847.

NSC Compound Enrichment Correlation
NSC 743853 Null 0.000307626816596602 0.23316606
NSC 747558 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one 0.000307626816596602 0.38654939
NSC 756134 GSK1023156A 0.000307626816596602 0.34606196
NSC 623527 Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt 0.000316293616993019 0.36479266
NSC 628114 9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride 0.000316293616993019 0.41775707
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.000316293616993019 0.45895111
NSC 132279 Null 0.000323852502732644 0.28746747
NSC 57187 Null 0.000323852502732648 0.35026674
NSC 673191 Null 0.000323852502732648 0.20595837
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.000323852502732648 0.36387521
Total:133  Current:3    [First] [Prev] [Next] [Last]